R. Drozdz et al., (D-(p-benzoylphenylalanine)(13), tyrosine(19))-melanin-concentrating hormone, a potent analogue for MCH receptor crosslinking, J PEPT SCI, 5(5), 1999, pp. 234-242
A photoreactive analogue of human melanin-concentrating hormone was designe
d, [D-Bpa(13), Tyr(19)]-MCH. containing the D-enantiomer of photolabile p-b
enzoylphenylalanine (Bpa) in position 13 and tyrosine for radioiodination i
n position 19. The linear peptide was synthesized by the continuous-flow so
lid-phase methodology using Fmoc-strategy and PEG-PS resins, purified to ho
mogeneity and cyclized by iodine oxidation. Radioiodination of [D-Bpa(13),T
yr(19)]-MCH at its Tyr(19) residue was carried out enzymatically using soli
d-phase bound glucose oxidase/lactoperoxidase, followed by purification on
a reversed-phase mini-column and HPLC. Saturation binding analysis of [I-12
5]-[D-Bpa(13),Tyr(19)]-MCH with G4F-7 mouse melanoma cells gave a K-D of 2.
2 +/- 0.2 x 10(-10) mol/l and a B-max of 1047 +/- 50 receptors/cell. Compet
ition binding analysis showed that MCH and rANF(1-28) displace [I-125]-[D-B
pa(13),Tyr(19)]-MCH from the MCH binding sites on G4F-7 cells whereas alpha
-MSH has no effect. Receptor crosslinking by UV-irradiation of G4F-7 cells
in the presence of [I-125]-[D-Bpa(13),Tyr(19)]-MCH followed by SDS-polyacry
lamide gel electrophoresis and autoradiography yielded a band of 45-50 kDa.
identical crosslinked bands were also detected in B16-F1 and G4F mouse mel
anoma cells, in RE and D10 human melanoma cells as well as in COS-7 cells.
Weak staining was found in rat PC12 phaeochromocytoma and Chinese hamster w
ary cells. No crosslinking was detected in human MP fibroblasts. These data
demonstrate that [I-125]-[D-Bpa(13),Tyr(19)]-MCH is a versatile photocross
linking analogue of MCH suitable to identify MCH receptors in different cel
ls and tissues; the MCH receptor in these cells appears to have the size of
a G protein-coupled receptor, most likely with a varying degree of glycosy
lation. Copyright (C) 1999 European Peptide Society and John Wiley & Sons,
Ltd.